A Value-Based Benefit for Musculoskeletal Conditions
The prevalence of pain has a tremendous impact on business, with an estimated annual cost of $61.2 billion in lost productive time alone
(Source: The Burden of Musculoskeletal Diseases in the United States). Traditional treatment models are costly and typically ineffective,
and the increasing number of treatment transactions
(tests, office visits, injections, surgical procedures and therapy) has not been accompanied by documented improvements in patient outcomes or disability rates.
|
As a result, health plans and payors are looking at a new insurance design that puts quality first—impacting both the bottom line and overall plan member health.
Adding Airrosti as a value-based benefit helps dramatically reduce costs, while significantly impacting the overall health and productivity of employees.
|

Airrosti is Different
Our patient time commitment and strong focus on patient outcomes is the foundation of our Best Practices Treatment Model.
While most physicians have limited one-on-one time with patients to perform clinical guidelines assessments, Airrosti Certified Providers take the time to thoroughly and accurately
diagnose each patient and identify the root cause of the injury or condition. This allows us to prevent unnecessary prescription of pharmaceuticals, injections, imaging and other diagnostic tests, specialist
visits and invasive surgical procedures. Our evidence-based approach achieves consistent, documented outcomes and allows your employees to return to work quickly and safely.
By adding Airrosti as a value-based benefit within your health plan, employees are encouraged to choose this higher value, evidence-based treatment option for their musculoskeletal conditions. Choosing Airrosti
first leads to immediate and lasting results while avoiding many unnecessary costs.